feed,title,long_url,short_url
SeekingAlpha,Syneos stock slumps 17% as FY22 outlook slashed on reimbursable expenses/forex impact,https://seekingalpha.com/news/3864810,
SeekingAlpha,"Eyes on sales of blockbuster drugs Eylea, Dupixent for Regeneron's Q2 2022 earnings",https://seekingalpha.com/news/3864805,
